How environmental toxicants and biological toxins alter intestinal defenses, microbial behavior and gastrointestinal health
By Carol Egan, M.Ed., CHHC, CNC
Environmental Health Researcher
In 2025, researchers demonstrated something extraordinary about pesticides and the human gut microbiome. Environmental chemicals used in agriculture changed which intestinal bacteria grew, which were inhibited, and the substances those bacteria produced. In a subsequent experiment, pesticide-induced changes in bacterial metabolism contributed to intestinal inflammation.
The significance reaches beyond pesticide exposure.
We tend to think about gastrointestinal microorganisms in terms of which ones are present, which are beneficial and which are pathogenic. But their behavior is influenced by the chemical and physiological conditions surrounding them.
And those conditions are constantly changing.
Pesticides, bisphenols, mycotoxins, heavy metals and airborne pollutants can interfere with the intestinal lining, alter microbial metabolism and disrupt protective functions that ordinarily regulate microbial populations.
Infections can further change this environment, sometimes leaving disturbances that persist long after the initial infection has resolved.
The relationship between environmental exposure, intestinal defenses and microbial activity is an important part of understanding persistent gastrointestinal dysfunction.
The Intestine Is an Active, Protective Environment
The intestinal tract maintains several defenses that regulate which organisms establish themselves and how they interact with the body.
Stomach acid limits the survival of many organisms entering through food and water. Bile acids influence microbial growth and metabolism. The migrating motor complex produces organized contractions that help clear residual food and bacteria from the small intestine between meals.
A mucus layer protects the intestinal epithelium, while tight junctions regulate passage between the cells lining the bowel.
Resident microorganisms contribute through colonization resistance, competing for nutrients and space and producing substances that help restrain potentially harmful organisms.
Together, these defenses influence microbial populations and protect the tissues beneath the intestinal lining.
Their importance becomes clearer when we examine the effects of environmental chemicals on the structures responsible for maintaining them.
Pesticides Change Microbial Growth and Metabolism
The 2025 Nature Communications study examined 306 combinations of pesticides and representative human gut bacterial species.
Researchers tested how exposure affected bacterial growth and measured the metabolic changes that followed.
The results were striking.
Some pesticides inhibited particular organisms while promoting the growth of others. Bacteria also accumulated several of the tested chemicals.
The investigators identified changes across hundreds of microbial metabolites, including compounds involved in amino acid, vitamin, carbohydrate and lipid metabolism. [1]
These metabolites matter because intestinal bacteria influence the host partly through the chemical substances they produce.
The researchers then examined one pesticide–bacteria interaction in mice and demonstrated that disrupted microbial lipid metabolism contributed to intestinal inflammation.
The findings establish a direct biological relationship:
Pesticide exposure altered bacterial populations and metabolic activity. The resulting metabolic disturbance contributed to intestinal inflammation in the experimental model.
The implications extend beyond the composition of a stool microbiome test.
Two microbial communities containing similar organisms need not have identical metabolic activity. The chemical environment can affect what those organisms produce and how those products interact with intestinal tissues.
This brings environmental toxicology directly into the study of microbial behavior.
Plastics and Mycotoxins Damage the Intestinal Barrier
Microorganisms are only one target of environmental exposure. The intestinal cells responsible for protecting us are another.
Consider bisphenol A (BPA), a chemical used in certain plastics and food-contact materials.
In a laboratory study involving human intestinal goblet cells, researchers demonstrated that BPA impaired mitochondrial function, reduced ATP production and increased oxidative stress.
These disturbances were accompanied by reduced production and secretion of mucin 2, a major component of the intestinal mucus layer. [2]
Goblet cells produce mucus that helps separate microorganisms from the epithelial cells beneath it.
When BPA disrupted mitochondrial activity, it also impaired a cellular function essential to maintaining this protective layer.
BPA exposure impaired mitochondrial energy production and mucus secretion, affecting two connected components of intestinal protection.
Other environmental compounds damage different parts of the barrier.
Deoxynivalenol, a mycotoxin produced by certain fungi and commonly investigated in contaminated grains, disrupts tight junction proteins that regulate movement between intestinal epithelial cells.
Experimental research has demonstrated reduced levels of tight junction proteins, including claudins and occludin, accompanied by increased intestinal permeability. [3]
These are measurable structural changes.
The mucus layer helps maintain separation between microorganisms and intestinal cells. Tight junctions regulate movement between those cells. Damage to either structure changes how the intestinal lining performs its protective work.
Consider these findings together.
Pesticides can alter the metabolism of intestinal microorganisms, changing the chemical substances they produce. BPA and mycotoxins can impair the intestinal structures that regulate contact between those microorganisms and the tissues beneath them.
Environmental exposures therefore act on both sides of the intestinal barrier: the microbial community occupying the intestinal lumen and the epithelial defenses separating that community from the host.
The findings come from different experimental systems, but the physiological relationship is clear. Microbial metabolites influence intestinal tissues, and the integrity of those tissues influences how the host encounters and responds to microbial products.
These are interacting biological processes, not isolated observations about bacteria and chemicals.
Heavy Metals and Air Pollution Extend the Exposure Picture
The gastrointestinal consequences of environmental exposure are not limited to substances unwittingly swallowed.
Cadmium and arsenic have been shown experimentally to disrupt intestinal epithelial integrity and alter proteins involved in maintaining the barrier.
In laboratory and animal models, cadmium exposure reduced epithelial adhesion proteins, while arsenic exposure changed tight junction regulation and increased intestinal permeability. [3,4]
These findings identify specific mechanisms through which toxic metals affect intestinal protection.
Air pollution provides another important line of evidence.
A systematic review and meta-analysis encompassing 70 epidemiological studies found that long-term exposure to fine particulate air pollution, known as PM2.5, was associated with increased risks of several gastrointestinal conditions.
For irritable bowel syndrome, the pooled analysis reported approximately 35% higher odds associated with the exposure contrast examined. [5]
This is population-level evidence of an association, not proof that air pollution caused IBS in any individual participant.
But it places gastrointestinal health within a broader environmental context.
Particulates enter through inhalation, while pesticides, mycotoxins and metals can enter through food and water. These exposures differ substantially in their chemistry and biological effects.
Yet research identifies intestinal barrier integrity, microbial metabolism and inflammatory signaling among the processes affected.
For a practitioner evaluating unexplained or persistent gastrointestinal findings, environmental history therefore extends beyond diet alone.
Intestinal Barrier Changes Can Precede Disease
A particularly important human study provides another perspective on the significance of intestinal protection.
Researchers followed 1,420 symptom-free first-degree relatives of people with Crohn’s disease, measuring intestinal permeability before participants developed symptoms.
Over a median follow-up of 7.8 years, 50 participants developed Crohn’s disease.
Those with abnormal intestinal permeability at the beginning of the study had approximately three times the subsequent risk of developing the condition.
The association remained significant when permeability had been measured more than three years before diagnosis. [6]
This is a remarkable finding because a measurable disturbance in intestinal barrier function preceded the development of disease.
Now place this alongside the experimental toxicology findings.
BPA impaired mucus secretion through mitochondrial dysfunction. Mycotoxins disrupted tight junction proteins. Cadmium and arsenic affected epithelial integrity.
The Crohn’s cohort establishes that barrier dysfunction can precede disease. The toxicology studies establish that specific environmental chemicals can damage components of that barrier.
The unresolved connection is which exposures contribute to early barrier dysfunction in susceptible individuals, and whether reducing those exposures changes subsequent disease risk.
The prospective study did not identify toxicants as the cause of increased permeability, but it establishes why investigating influences on barrier integrity matters before a diagnosis is made.
This is a more useful clinical consideration than treating permeability as an isolated laboratory finding.
Pathogens Can Leave the Terrain Altered
The relationship also operates in the other direction. Microorganisms can change their intestinal environment.
Giardia, a protozoan parasite that infects the small intestine, provides an instructive example.
Following a waterborne outbreak in Bergen, Norway, researchers tracked people with confirmed infection.
Ten years later, 43% of previously infected respondents reported irritable bowel syndrome, compared with 14% of uninfected controls. [7]
The original infection was a documented event. The gastrointestinal consequences remained associated with that event a decade later.
Separate experimental work helps explain how such persistence occurs.
Researchers exposed bacterial communities cultured from human intestinal biopsies to Giardia.
The parasite changed both the composition and structure of those communities. The disturbances remained in the laboratory system after the parasite had been eliminated.
Further experiments showed that the altered communities promoted bacterial invasion, disrupted epithelial tight junctions and increased inflammatory signaling. [8]
The two studies provide complementary evidence.
Human follow-up demonstrated persistent gastrointestinal illness after infection. Experimental research demonstrated that Giardia can leave microbial communities altered after the organism itself has been removed.
The distinction matters for recurrent or persistent symptoms.
Successful treatment of an infectious organism does not necessarily lead to lasting restoration of intestinal function, particularly when the infection has left physiological disturbances or other contributing stressors remain unaddressed.
Why Recurrence Demands a Wider Investigation
Small intestinal bacterial overgrowth (SIBO) illustrates the clinical importance of this distinction.
In a study of 80 patients successfully treated with rifaximin, researchers repeated breath testing over nine months.
By the final assessment, 43.7% had developed a positive breath test again. [9]
The study did not establish environmental toxicity as the cause.
It did demonstrate that removing bacterial overgrowth does not necessarily prevent its return.
Normal small-intestinal function depends on acid secretion, coordinated motility, anatomical integrity and other protective mechanisms.
If a disturbance affecting one of those defenses remains, bacterial overgrowth can recur after initially successful treatment.
The environmental research adds another area worth evaluating when the patient’s exposure history supports it. Chemical toxicants can influence microbial activity, epithelial integrity and intestinal physiology.
The clinical distinction is important: antimicrobial treatment addresses bacterial accumulation, while preventing recurrence also requires attention to the conditions that permit that accumulation.
Restoring Microbial Ecology Changes Clinical Outcomes
The strongest clinical demonstration of the importance of intestinal ecology comes from recurrent Clostridioides difficileinfection.
After antibiotic treatment, the resident microbial community can remain depleted, reducing the resistance that normally restrains C. difficile.
A randomized trial involving 182 patients tested an oral microbiome therapy containing purified bacterial spores, administered after standard antibiotic treatment.
Within eight weeks, C. difficile recurred in 12% of patients receiving microbiome therapy, compared with 40% receiving placebo. [10]
Researchers also documented changes in microbial populations and bile-acid metabolism, both involved in resistance to C. difficile.
The result demonstrates that restoring microbial ecology following antimicrobial treatment can substantially reduce recurrence in a defined clinical population.
This is not evidence that environmental toxicants caused C. difficile infection.
It is direct clinical evidence that microbial ecology contributes to whether an organism remains controlled after treatment.
Viewed together, the Giardia, SIBO and C. difficile studies identify three different aspects of persistence.
Giardia demonstrates that infection can leave lasting microbial disturbances. SIBO demonstrates that overgrowth can return after successful treatment. The C. difficile trial demonstrates that restoring microbial ecology can substantially reduce recurrence.
Identifying or eliminating an organism, correcting the conditions that permit its proliferation, and restoring normal intestinal function are related but distinct clinical objectives.
Environmental exposures belong in this investigation because toxicology research establishes their effects on several of the same microbial and epithelial processes.
Bringing Environmental Research Into the Clinical Assessment
Consider the patient who presents with recurrent abdominal discomfort, bloating, altered bowel habits or inflammatory findings.
The clinical investigation appropriately considers infection, intestinal motility, diet, medications, immune activity and structural abnormalities.
Peer-reviewed environmental history supplies another category of relevant information.
Agricultural or occupational pesticide exposure, contaminated food or water, toxic metals, plastic-associated chemicals and airborne pollutants each raise different questions about exposure and biological effect.
The laboratory and epidemiological findings reviewed here identify mechanisms and associations that help determine which exposures deserve attention.
An intestinal barrier disturbance does not identify its cause. A change in microbial composition does not establish why the change occurred. A positive pathogen test does not describe every influence on the surrounding tissues.
Each finding provides a particular piece of information.
The value of environmental health research is in showing how these pieces relate, identifying physiological effects that merit consideration, and bringing that knowledge into patient assessment.
A Different Understanding of Intestinal Terrain
The most important finding emerging from this research is that the intestinal environment is not static.
Pesticides change bacterial growth and metabolism. BPA impairs the cells responsible for producing protective mucus. Mycotoxins and metals disrupt intestinal barrier structures. Air pollution is associated with gastrointestinal disease in human populations.
Infections can change microbial communities long after the initial episode, and clinical trials demonstrate that restoring microbial ecology can alter the risk of recurrence.
The research documents effects on both the organisms occupying the intestine and the tissues responsible for regulating their activity.
It also demonstrates why the presence of an organism alone cannot explain every clinical outcome.
The organism’s characteristics matter. So do the integrity of the intestinal lining, the surrounding microbial community, immune activity, motility and the chemical conditions in which these processes operate.
The intestinal terrain influences microbial behavior, and microbial activity can alter the terrain in return.
Environmental toxicants and biological toxins belong in this relationship because they can act directly on the microorganisms, on the host’s protective tissues, or on both.
Understanding these connections gives practitioners a more complete physiological framework for investigating persistent gastrointestinal dysfunction.
The intestinal environment is not merely where gastrointestinal disease occurs. Its biological condition is part of what determines how the intestine functions, how microorganisms behave and how the host responds.
Research References
[1] Chen L, Yan H, Di S, et al. Mapping pesticide-induced metabolic alterations in human gut bacteria. Nature Communications. 2025;16:4355. https://doi.org/10.1038/s41467-025-59747-6
[2] Zhao Z, Qu W, Wang K, et al. Bisphenol A inhibits mucin 2 secretion in intestinal goblet cells through mitochondrial dysfunction and oxidative stress. Biomedicine & Pharmacotherapy. 2019;111:901–908. https://pubmed.ncbi.nlm.nih.gov/30841469/
[3] Gao Y, Meng L, Liu H, Wang J, Zheng N. The Compromised Intestinal Barrier Induced by Mycotoxins. Toxins. 2020;12:619. https://doi.org/10.3390/toxins12100619
[4] Domene A, et al. Impact of chronic exposure to arsenate through drinking water on the intestinal barrier. Chemical Research in Toxicology. 2023;36:1372–1385. https://doi.org/10.1021/acs.chemrestox.3c00201
[5] Exposure to air pollution and risk of gastrointestinal diseases: a systematic review and meta-analysis of epidemiological evidence. 2026. https://pubmed.ncbi.nlm.nih.gov/41995397/
[6] Increased Intestinal Permeability Is Associated With Later Development of Crohn’s Disease. Gastroenterology. 2020. https://pubmed.ncbi.nlm.nih.gov/32791132/
[7] Litleskare S, et al. Prevalence of Irritable Bowel Syndrome and Chronic Fatigue 10 Years After Giardia Infection. Clinical Gastroenterology and Hepatology. 2018;16:1064–1072. https://pubmed.ncbi.nlm.nih.gov/29378314/
[8] Beatty JK, Akierman SV, Motta JP, et al. Giardia duodenalis induces pathogenic dysbiosis of human intestinal microbiota biofilms. International Journal for Parasitology. 2017;47:311–326. https://pubmed.ncbi.nlm.nih.gov/28237889/
[9] Lauritano EC, Gabrielli M, Scarpellini E, et al. Small intestinal bacterial overgrowth recurrence after antibiotic therapy. American Journal of Gastroenterology. 2008;103:2031–2035. https://pubmed.ncbi.nlm.nih.gov/18802998/
[10] Feuerstadt P, Louie TJ, Lashner B, et al. SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. New England Journal of Medicine. 2022;386:220–229. https://pubmed.ncbi.nlm.nih.gov/35045228/




Leave a Reply